Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasmonic Photothermal Therapy of Flow-Limiting Atherosclerotic Lesions With Silica-Gold Nanoparticles: a First-in-Man Study

NCT01270139 is registered in ClinicalTrials.gov with Ural State Medical University as lead sponsor.

NCT NCT01270139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01270139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasmonic Photothermal Therapy of Flow-Limiting Atherosclerotic Lesions With Silica-Gold Nanoparticles: a First-in-Man Study
Lead sponsor
Ural State Medical University
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2007
Completion date
August 1, 2016
Enrollment
180 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, heart failure, multivessel coronary artery disease, stable angina